The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 8,422 | 1,684,364 | SH | SOLE | 1,684,364 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 887,684 | 25,819,768 | SH | SOLE | 25,819,768 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 761 | 28,765 | SH | SOLE | 28,765 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 115,613 | 4,582,382 | SH | SOLE | 4,582,382 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 7,816 | 1,856,637 | SH | SOLE | 1,856,637 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 69,338 | 3,301,791 | SH | SOLE | 3,301,791 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 3,021 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 551 | 100,000 | SH | SOLE | 600,000 | 0 | 0 | ||
Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | 88,557 | 2,221,706 | SH | SOLE | 4,443,412 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 1,415 | 189,987 | SH | SOLE | 189,987 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 13,576 | 299,356 | SH | SOLE | 299,356 | 0 | 0 | ||
Aevi Genomic Medicine, Inc. | COM | 00835P105 | 3,010 | 1,618,089 | SH | SOLE | 1,618,089 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 920 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 7,514 | 128,666 | SH | SOLE | 128,666 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 14,644 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Akari Therapeutics plc | SPONSORED ADR | 00972G108 | 5,501 | 496,901 | SH | SOLE | 49,690,100 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 4,520 | 217,328 | SH | SOLE | 217,328 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 793,410 | 6,544,130 | SH | SOLE | 6,544,130 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 8,790 | 150,251 | SH | SOLE | 150,251 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 72,501 | 22,656,469 | SH | SOLE | 22,656,469 | 0 | 0 | ||
AnaptysBio, Inc. | COM ADDED | 032724106 | 4,163 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 182,491 | 10,934,154 | SH | SOLE | 10,934,154 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 587 | 180,582 | SH | SOLE | 180,582 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 14,178 | 1,585,913 | SH | SOLE | 1,585,913 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 37,841 | 1,351,463 | SH | SOLE | 1,351,463 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 6,373 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
AveXis, Inc. | COM | 05366U100 | 38,015 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 134,475 | 3,673,175 | SH | SOLE | 47,751,275 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 62,099 | 5,032,313 | SH | SOLE | 5,032,313 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 98,421 | 11,716,784 | SH | SOLE | 11,716,784 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 399 | 210,021 | SH | SOLE | 210,021 | 0 | 0 | ||
Biogen Inc. | COM | 09062X103 | 4,511 | 16,500 | SH | SOLE | 16,500 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 421,913 | 4,806,483 | SH | SOLE | 4,806,483 | 0 | 0 | ||
BioPharmX Corporation | COM | 09072X101 | 191 | 377,295 | SH | SOLE | 377,295 | 0 | 0 | ||
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 12 | 20,084 | SH | SOLE | 20,084 | 0 | 0 | ||
Bioverativ Inc. | COM ADDED | 09075E100 | 449 | 8,249 | SH | SOLE | 8,249 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 31,946 | 351,441 | SH | SOLE | 351,441 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 9,949 | 5,102,153 | SH | SOLE | 5,102,153 | 0 | 0 | ||
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,200 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 58,087 | 13,053,275 | SH | SOLE | 13,053,275 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 357 | 49,064 | SH | SOLE | 49,064 | 0 | 0 | ||
Chimerix, Inc. | COM | 16934W106 | 735 | 115,216 | SH | SOLE | 115,216 | 0 | 0 | ||
ContraFect Corporation | COM | 212326102 | 7,283 | 4,045,876 | SH | SOLE | 4,045,876 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | COM | 21833P103 | 1,074 | 130,129 | SH | SOLE | 130,129 | 0 | 0 | ||
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 83 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 6,078 | 1,413,499 | SH | SOLE | 1,413,499 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 194,047 | 5,509,560 | SH | SOLE | 2,754,780 | 0 | 0 | ||
Dermira, Inc. | COM | 24983L104 | 14,171 | 415,448 | SH | SOLE | 415,448 | 0 | 0 | ||
Dimension Therapeutics, Inc. | COM | 25433V105 | 2,191 | 1,251,881 | SH | SOLE | 1,251,881 | 0 | 0 | ||
Dynavax Technologies Corporation | COM NEW | 268158201 | 446 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 3,987 | 232,481 | SH | SOLE | 232,481 | 0 | 0 | ||
Exelixis, Inc. | COM | 30161Q104 | 56,419 | 2,603,569 | SH | SOLE | 2,603,569 | 0 | 0 | ||
Five Prime Therapeutics, Inc. | COM | 33830X104 | 696 | 19,247 | SH | SOLE | 19,247 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 12,210 | 2,466,702 | SH | SOLE | 2,466,702 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 1,365 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 22,400 | 259,894 | SH | SOLE | 259,894 | 0 | 0 | ||
Genomic Health, Inc. | COM | 37244C101 | 433,648 | 13,770,982 | SH | SOLE | 13,770,982 | 0 | 0 | ||
GlycoMimetics, Inc. | COM | 38000Q102 | 2,070 | 381,235 | SH | SOLE | 381,235 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 18,034 | 1,391,507 | SH | SOLE | 1,391,507 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 41,754 | 2,783,569 | SH | SOLE | 2,783,569 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 25,408 | 10,286,483 | SH | SOLE | 10,286,483 | 0 | 0 | ||
Ignyta, Inc. | COM | 451731103 | 4,911 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Immune Design Corp. | COM | 45252L103 | 1,013 | 148,937 | SH | SOLE | 148,937 | 0 | 0 | ||
ImmunoGen, Inc. | COM | 45253H101 | 11,669 | 3,015,353 | SH | SOLE | 3,015,353 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 4,559,485 | 34,110,011 | SH | SOLE | 34,110,011 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,875 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 7,004 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 14,965 | 1,062,120 | SH | SOLE | 1,062,120 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 9,899 | 609,166 | SH | SOLE | 609,166 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 80,609 | 7,288,300 | SH | SOLE | 7,288,300 | 0 | 0 | ||
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 1,620 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Jounce Therapeutics, Inc. | COM ADDED | 481116101 | 2,199 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Juno Therapeutics, Inc. | COM | 48205A109 | 1,110 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | COM | 48576U106 | 2,786 | 216,990 | SH | SOLE | 216,990 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 11,317 | 379,134 | SH | SOLE | 379,134 | 0 | 0 | ||
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 7,767 | 73,386 | SH | SOLE | 73,386 | 0 | 0 | ||
Loxo Oncology, Inc. | COM | 548862101 | 5,796 | 137,735 | SH | SOLE | 137,735 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 6,764 | 363,676 | SH | SOLE | 363,676 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 890 | 57,762 | SH | SOLE | 57,762 | 0 | 0 | ||
MediWound Ltd. | ORD SHS | M68830104 | 1,492 | 226,000 | SH | SOLE | 226,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 28,293 | 1,160,014 | SH | SOLE | 1,160,014 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 11,800 | 2,269,198 | SH | SOLE | 2,269,198 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 1,315 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | 4,200 | 350,000 | SH | SOLE | 35,000 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 2,028 | 228,676 | SH | SOLE | 228,676 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 38,772 | 895,422 | SH | SOLE | 895,422 | 0 | 0 | ||
NeuroDerm Ltd. | ORD SHS | M74231107 | 15,178 | 571,667 | SH | SOLE | 571,667 | 0 | 0 | ||
Palatin Technologies, Inc. | COM PAR $.01 | 696077403 | 671 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 29,744 | 3,150,808 | SH | SOLE | 3,150,808 | 0 | 0 | ||
Proteon Therapeutics, Inc. | COM | 74371L109 | 523 | 298,591 | SH | SOLE | 298,591 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 3,789 | 177,952 | SH | SOLE | 177,952 | 0 | 0 | ||
Rigel Pharmaceuticals, Inc. | COM NEW | 766559603 | 8,337 | 2,518,882 | SH | SOLE | 2,518,882 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 568 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 14,806 | 208,328 | SH | SOLE | 208,328 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 23,561 | 4,530,901 | SH | SOLE | 4,530,901 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 2,873,680 | 45,715,556 | SH | SOLE | 45,715,556 | 0 | 0 | ||
Selecta Biosciences, Inc. | COM | 816212104 | 2,516 | 175,712 | SH | SOLE | 175,712 | 0 | 0 | ||
Seres Therapeutics, Inc. | COM | 81750R102 | 1,409 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 70,320 | 1,318,341 | SH | SOLE | 1,318,341 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 1,952 | 219,298 | SH | SOLE | 219,298 | 0 | 0 | ||
Stemline Therapeutics, Inc. | COM | 85858C107 | 5,416 | 633,497 | SH | SOLE | 633,497 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 3,041 | 741,665 | SH | SOLE | 741,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 3,257 | 204,465 | SH | SOLE | 204,465 | 0 | 0 | ||
Tonix Pharmaceuticals Holdings Corp. | COM ADDED | 890260409 | 2,099 | 449,500 | SH | SOLE | 449,500 | 0 | 0 | ||
Trevena, Inc. | COM | 89532E109 | 3,146 | 857,206 | SH | SOLE | 857,206 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 2,544 | 413,697 | SH | SOLE | 413,697 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 3,389 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Versartis, Inc. | COM | 92529L102 | 35,454 | 1,660,593 | SH | SOLE | 1,660,593 | 0 | 0 | ||
Windtree Therapeutics, Inc. | COM | 97382D105 | 291 | 254,973 | SH | SOLE | 254,973 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 20,860 | 872,072 | SH | SOLE | 872,072 | 0 | 0 | ||
Zogenix, Inc. | COM NEW | 98978L204 | 4,144 | 381,939 | SH | SOLE | 381,939 | 0 | 0 | ||
Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | 29,696 | 35,083,000 | PRN | SOLE | 35,083,000 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | NOTE 2.0% 8/15/2019 | 00767EAB8 | 13,241 | 16,517,000 | PRN | SOLE | 16,517,000 | 0 | 0 | ||
Array BioPharma Inc. | NOTE 3.0% 6/1/2020 | 04269XAA3 | 4,258 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 1.875% 4/23/2017 | 09061GAD3 | 95,967 | 22,379,000 | PRN | SOLE | 22,379,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | 13,830 | 12,228,000 | PRN | SOLE | 12,228,000 | 0 | 0 | ||
Inotek Pharmaceuticals Corporation | NOTE 5.75% 8/1/2021 | 45780VAB8 | 3,008 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Novavax, Inc. | Note 3.75% 2/1/2023 ADDED | 670002AB0 | 48,554 | 108,500,000 | PRN | SOLE | 108,500,000 | 0 | 0 | ||
Protalix BioTherapeutics, Inc. | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,543 | 3,423,000 | PRN | SOLE | 3,423,000 | 0 | 0 |